BSE Live
Nov 11, 16:01Prev. Close
9086.60
Open Price
9020.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 11, 15:51Prev. Close
9083.00
Open Price
9042.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
9150.00 (13)
| Cash Flow of AstraZeneca Pharma (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 113.97 | 72.67 | 43.80 | 35.50 | 5.76 | |
| Net CashFlow From Operating Activities | 87.42 | 54.98 | 8.79 | 38.10 | 56.99 | |
| Net Cash Used In Investing Activities | -170.80 | 4.28 | -9.36 | 0.25 | -3.61 | |
| Net Cash Used From Financing Activities | -6.36 | 0.00 | 0.00 | 0.00 | -0.51 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -89.74 | 59.26 | -0.57 | 38.35 | 52.87 | |
| Cash And Cash Equivalents Begin of Year | 173.24 | 113.98 | 114.55 | 76.20 | 23.33 | |
| Cash And Cash Equivalents End Of Year | 83.50 | 173.24 | 113.98 | 114.55 | 76.20 |
10.11.2025
31.07.2025
06.06.2025
AstraZeneca Standalone March 2025 Net Sales at Rs 480.48 crore, up 25.39% Y-o-Y
07.04.2025
06.06.2025
AstraZeneca Standalone March 2025 Net Sales at Rs 480.48 crore, up 25.39% Y-o-Y
17.02.2025
AstraZeneca Standalone December 2024 Net Sales at Rs 440.29 crore, up 43.98% Y-o-Y
21.11.2024
AstraZeneca Standalone September 2024 Net Sales at Rs 408.00 crore, up 31.16% Y-o-Y
13.08.2024
AstraZeneca Standalone June 2024 Net Sales at Rs 387.52 crore, up 31.16% Y-o-Y